Long term (current) use of Janus kinase inhibitor

This code signifies a patient's ongoing, current use of a Janus kinase (JAK) inhibitor medication. JAK inhibitors are a class of targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs) used to treat various autoimmune and inflammatory conditions by blocking specific signaling pathways within cells. This code indicates the patient is actively receiving this therapy for long-term management.

Apply this code when documenting a patient's current, continuous prescription and use of a JAK inhibitor for conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, atopic dermatitis, or other autoimmune diseases. This code is used to capture the medication's ongoing impact on the patient's health status and treatment plan, regardless of the primary diagnosis for which it is prescribed.

• Always code this in conjunction with the primary diagnosis for which the JAK inhibitor is being used.
• Ensure the patient is actively taking the medication; do not use for past use or if the medication has been discontinued.
• Differentiate from other long-term medication use codes based on the specific drug class (JAK inhibitor).